Dr Paolo Spingardi joined UCLB in 2022. He has previously worked in the industry partnerships and commercialisation team in the Imperial College London enterprise division and was a Fellow of the LifeArc Technology Transfer Programme.

Paolo has an MChem in chemistry and a DPhil in cancer metabolism and epigenetics from the University of Oxford. In his research he developed flux analysis systems to measure the activities of the nucleotide synthesis and salvage pathways in cancer.